Three New Peer-reviewed Publications Further Validate the Benefits of ...
A number of studies have validated the benefits of Hologic's 3D mammography technology in screening: a simultaneous increase in cancer detection rates, for invasive cancers in particular, and a significant reduction in unnecessary patient recalls.
Hologic stock regains some ground
Hologic Inc. regained some ground after two down days following its release of quarterly results that included a net loss of $5.4 million, or 2 cents per diluted share.
Hologic's new CEO predicts no major divestitures
In his first conference call with analysts since becoming CEO of Hologic , Stephen MacMillan said that while the company may sell off some of its smaller parts, he expects "no major changes to our corporate structure."
Hologic Announces First Quarter Fiscal 2014 Operating Results
The Company's definitions of these non-GAAP financial measures, and the reconciliations of these measures to the Company's comparable GAAP financial measures for the periods presented, are set forth in the supplemental information attached to this press release.